The U.S. Meals and Drug Administration (FDA) has granted breakthrough remedy designation to zovegalisib together with Faslodex (fulvestrant) for some sufferers with...
The U.S. Meals and Drug Administration (FDA) has granted quick monitor designation to pelareorep, an investigational immunotherapy developed by Oncolytics Biotech, to...
